Associated Papers
Dissecting the biological impact of GBA1 mutations using multi-omics in an isogenic setting.
Jerez PÁ et al.
Biorxiv : the Preprint Server for Biology, 2025
A Comparative Biochemical and Pathological Evaluation of Brain Samples from Knock-In Murine Models of Gaucher Disease.
Furderer ML et al.
International Journal of Molecular Sciences, 2024
Levodopa-induced dyskinesia in early-onset Parkinson's disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand.
Thanprasertsuk S et al.
Plos One, 2023
C-X-C Motif Chemokine Ligand 9 and Its CXCR3 Receptor Are the Salt and Pepper for T Cells Trafficking in a Mouse Model of Gaucher Disease.
Magnusen AF et al.
International Journal of Molecular Sciences, 2021
Exploring genetic modifiers of Gaucher disease: The next horizon.
Davidson BA et al.
Human Mutation, 2018
Assessing risk for Mendelian disorders in a Bronx population.
diSibio G et al.
Molecular Genetics & Genomic Medicine, 2017
28944235 (PubMed )
Supplement: MGG3-5-516-s001.xlsx › Table_S2
Gaucher disease paradigm: from ERAD to comorbidity.
Bendikov-Bar I et al.
Human Mutation, 2012
Hematologically important mutations: Gaucher disease.
Beutler E et al.
Blood Cells, Molecules & Diseases, 0
Select a paper to view details